ZIVO Bioscience, Inc. filed its 10-K on Mar 14, 2023 for the period ending Dec 31, 2022. In this report its auditor, BDO LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.98 USD | +1.92% | +13.19% | +565.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+565.00% | 22.37M | |
+16.86% | 8.48B | |
+6.26% | 7.6B | |
+4.89% | 6.39B | |
-5.81% | 3.75B | |
-6.58% | 3.71B | |
-3.55% | 1.36B | |
-28.31% | 1.11B | |
+18.12% | 1.02B | |
-9.14% | 924M |
- Stock Market
- Equities
- ZIVO Stock
- News ZIVO Bioscience, Inc.
- ZIVO Bioscience, Inc. Auditor Raises 'Going Concern' Doubt